Scan to Download
One power score. Smarter investment decisions
Acrivon Therapeutics Inc
ACRV1.630USD
-0.040-2.40%
Close 09/19, 16:00（ET）Quotes delayed by 15 min
USD0.000After-hours (ET)
51.26MMarket Cap
LossP/E TTM
Acrivon Therapeutics Inc
1.630
-0.040-2.40%
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
Operating expenses
5.65%22.65M
22.61%21.66M
18.53%24.95M
55.79%25.14M
38.13%21.44M
22.75%17.67M
111.69%21.05M
68.53%16.14M
--15.52M
--14.39M
--9.95M
--9.57M
R&D expenses
7.70%16.18M
34.35%15.41M
20.36%18.63M
83.73%18.86M
42.81%15.03M
17.58%11.47M
164.04%15.48M
29.27%10.27M
--10.52M
--9.76M
--5.86M
--7.94M
Depreciation, depletion, and amortization
46.93%335.00K
38.84%311.00K
103.36%303.00K
125.56%300.00K
76.74%228.00K
79.20%224.00K
-25.50%149.00K
14.66%133.00K
--129.00K
--125.00K
--200.00K
--116.00K
Operating profit
-5.65%-22.65M
-22.61%-21.66M
-18.53%-24.95M
-55.79%-25.14M
-38.13%-21.44M
-22.75%-17.67M
-111.69%-21.05M
-68.53%-16.14M
---15.52M
---14.39M
---9.95M
---9.57M
Net non-operating interest income (expenses)
Non-operating interest income
-35.78%1.73M
38.04%2.00M
--2.36M
--2.70M
--2.69M
--1.45M
----
----
----
----
----
----
Special income (expenses)
----
----
----
----
----
----
----
----
----
----
--0.00
--0.00
Other non-operating income (expenses)
-58.18%-87.00K
94.70%-14.00K
-113.33%-240.00K
-99.94%1.00K
-103.42%-55.00K
-116.13%-264.00K
77.26%1.80M
343.24%1.67M
--1.61M
--1.64M
--1.02M
--377.00K
Income before tax
-11.75%-21.01M
-19.37%-19.68M
-18.59%-22.83M
-55.13%-22.44M
-35.10%-18.80M
-29.24%-16.49M
-115.61%-19.25M
-57.27%-14.47M
---13.91M
---12.76M
---8.93M
---9.20M
Income after tax
-11.75%-21.01M
-19.37%-19.68M
-18.59%-22.83M
-55.13%-22.44M
-35.10%-18.80M
-29.24%-16.49M
-115.61%-19.25M
-57.27%-14.47M
---13.91M
---12.76M
---8.93M
---9.20M
Net income from continuous operations
-11.75%-21.01M
-19.37%-19.68M
-18.59%-22.83M
-55.13%-22.44M
-35.10%-18.80M
-29.24%-16.49M
-115.61%-19.25M
-57.27%-14.47M
---13.91M
---12.76M
---8.93M
---9.20M
Net income attributable to controlling interests
-11.75%-21.01M
-19.37%-19.68M
-18.59%-22.83M
-55.13%-22.44M
-35.10%-18.80M
-29.24%-16.49M
-115.61%-19.25M
-57.27%-14.47M
---13.91M
---12.76M
---8.93M
---9.20M
Net income attributable to common shareholders
-11.75%-21.01M
-19.37%-19.68M
-18.59%-22.83M
-55.13%-22.44M
-35.10%-18.80M
-29.24%-16.49M
-115.61%-19.25M
-57.27%-14.47M
---13.91M
---12.76M
---8.93M
---9.20M
Basic earnings per share
-4.98%-0.55
29.68%-0.51
30.79%-0.60
10.11%-0.59
17.85%-0.52
-25.41%-0.73
-111.58%-0.86
-48.58%-0.66
---0.63
---0.58
---0.41
---0.44
Diluted earnings per share
-4.98%-0.55
29.68%-0.51
30.79%-0.60
10.11%-0.59
17.85%-0.52
-25.41%-0.73
-111.58%-0.86
-48.58%-0.66
---0.63
---0.58
---0.41
---0.44
Dividend per share
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
Currency unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit opinions
--
--
--
--
--
--
--
--
--
--
--
--
